Skip to main content
. 2014 Nov 18;19(11):19021–19035. doi: 10.3390/molecules191119021

Table 1.

Antiproliferative activity of the artemisinin-indoloquinoline hybrids against human leukemia MV4-11 cell line.

Compound R1 R2 R3 MV4-11 a IC50 (μM)
cisplatin 2.820 ± 0.450
doxorubicin HCl 0.006 ± 0.002
7a H H H 0.286 ± 0.079
7b Cl CH3 CH3 0.072 ± 0.022
7c Br CH3 CH3 0.242 ± 0.031
7d CO2Me H H 0.148 ± 0.015
7e CO2Me CH3 CH3 0.075 ± 0.001
7f CO2Me H OH 0.226 ± 0.019
8 0.286 ± 0.127
4a b H H H 0.066 ± 0.023
4d c CO2Me H H 0.086 ± 0.020
6 d 0.124 ± 0.010

a MV4-11, human leukemia cell line; b Reference [50]; c Reference [51]; d Activity against MV4-11 of the compound 9 derived from 6 and artesunate 3 is cited in Reference [54].